Literature DB >> 8709203

Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication.

V E Buckwold1, Z Xu, M Chen, T S Yen, J H Ou.   

Abstract

The basal core promoter (BCP) of hepatitis B virus (HBV) controls the transcription of both the precore RNA and the core RNA. The precore RNA codes for the secreted e antigen, while the core RNA codes for the major core protein and the DNA polymerase and also is the pregenomic RNA. The double mutation of nucleotides 1762 and 1764 in the BCP from A and G to T and A, respectively, is frequently observed in HBV sequences isolated from chronic patients. Several papers have reported conflicting results regarding whether this double mutation is important for e antigen expression. In order to address this issue, we have introduced this double mutation into the HBV genome and studied its effects on HBV gene expression and replication. Our results indicate that the mutated BCP can no longer bind a liver-enriched transcription factor(s) and that the transcription of only precore RNA and, consequently, the expression of e antigen were reduced. The reduction of precore gene expression was accompanied by an increase in progeny virus production. This increase was found to occur at or immediately prior to the encapsidation of the pregenomic RNA. Thus, the results of our in vitro study resolve the discrepancy of previous clinical observations and indicate that this double mutation suppresses but does not abolish the e antigen phenotype. The implications of these findings in the pathogenesis of HBV are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8709203      PMCID: PMC190601          DOI: 10.1128/JVI.70.9.5845-5851.1996

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Translational inactivation of RNA function: discrimination against a subset of genomic transcripts during HBV nucleocapsid assembly.

Authors:  M Nassal; M Junker-Niepmann; H Schaller
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

2.  A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells.

Authors:  N C Andrews; D V Faller
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

3.  Characterization of the hepatitis B virus EnhI enhancer and X promoter complex.

Authors:  W T Guo; K D Bell; J H Ou
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

4.  Proteolytic conversion of hepatitis B virus e antigen precursor to end product occurs in a postendoplasmic reticulum compartment.

Authors:  J Wang; A S Lee; J H Ou
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

5.  Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

Authors:  W F Carman; M R Jacyna; S Hadziyannis; P Karayiannis; M J McGarvey; A Makris; H C Thomas
Journal:  Lancet       Date:  1989-09-09       Impact factor: 79.321

6.  Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?

Authors:  D R Milich; J E Jones; J L Hughes; J Price; A K Raney; A McLachlan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

7.  Active hepatitis B virus replication in the presence of anti-HBe is associated with viral variants containing an inactive pre-C region.

Authors:  S P Tong; J S Li; L Vitvitski; C Trépo
Journal:  Virology       Date:  1990-06       Impact factor: 3.616

8.  Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: trans-activation and repression by CCAAT/enhancer binding protein.

Authors:  M López-Cabrera; J Letovsky; K Q Hu; A Siddiqui
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

9.  The role of envelope proteins in hepatitis B virus assembly.

Authors:  V Bruss; D Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

10.  Targeting of the hepatitis B virus precore protein to the endoplasmic reticulum membrane: after signal peptide cleavage translocation can be aborted and the product released into the cytoplasm.

Authors:  P D Garcia; J H Ou; W J Rutter; P Walter
Journal:  J Cell Biol       Date:  1988-04       Impact factor: 10.539

View more
  137 in total

1.  Early mutation of precore (A1896) region prior to core promoter region mutation leads to decrease of HBV replication and remission of hepatic inflammation.

Authors:  Y Karino; J Toyota; T Sato; T Ohmura; K Yamazaki; T Suga; K Nakamura; M Sugawara; T Matsushima; K Hino
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

2.  Differential regulation of hepatitis B virus core protein expression and genome replication by a small upstream open reading frame and naturally occurring mutations in the precore region.

Authors:  Li Zong; Yanli Qin; Haodi Jia; Lei Ye; Yongxiang Wang; Jiming Zhang; Jack R Wands; Shuping Tong; Jisu Li
Journal:  Virology       Date:  2017-03-03       Impact factor: 3.616

3.  In vitro and in vivo interactions between the hepatitis B virus protein P22 and the cellular protein gC1qR.

Authors:  S Lainé; A Thouard; J Derancourt; M Kress; D Sitterlin; J-M Rossignol
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

4.  High level of hepatitis B virus DNA after HBeAg-to-anti-HBe seroconversion is related to coexistence of mutations in its precore and basal core promoter.

Authors:  Xiao-Mou Peng; Gui-Mei Huang; Jian-Guo Li; Yang-Su Huang; Yong-Yu Mei; Zhi-Liang Gao
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

Review 5.  Update of research and management of hepatitis B.

Authors:  Takeshi Okanoue; Masahito Minami
Journal:  J Gastroenterol       Date:  2006-02       Impact factor: 7.527

6.  Improved method for rapid and efficient determination of genome replication and protein expression of clinical hepatitis B virus isolates.

Authors:  Yanli Qin; Jiming Zhang; Tamako Garcia; Kiyoaki Ito; Danielle Gutelius; Jisu Li; Jack Wands; Shuping Tong
Journal:  J Clin Microbiol       Date:  2011-02-02       Impact factor: 5.948

7.  Mechanisms of inhibition of nuclear hormone receptor-dependent hepatitis B virus replication by hepatocyte nuclear factor 3beta.

Authors:  Hong Tang; Alan McLachlan
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  Prevalence of mutations in core promoter/precore region in Japanese patients with chronic hepatitis B virus infection.

Authors:  A Nagasaka; S Hige; M Marutani; I Tsunematsu; M Saito; Y Yamamoto; S Konishi; M Asaka
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

9.  Genotype and phylogenetic characterization of hepatitis B virus among multi-ethnic cohort in Hawaii.

Authors:  Mayumi Sakurai; Fuminaka Sugauchi; Naoky Tsai; Seiji Suzuki; Izumi Hasegawa; Kei Fujiwara; Etsuro Orito; Ryuzo Ueda; Masashi Mizokami
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

Review 10.  The evolution and clinical impact of hepatitis B virus genome diversity.

Authors:  Peter A Revill; Thomas Tu; Hans J Netter; Lilly K W Yuen; Stephen A Locarnini; Margaret Littlejohn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-28       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.